Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Become EABM
Become Reviewer

Volume 20 - Issue 2



Meet Our Section Editor promotion: free to download

Volume: 20   Issue: 2
Pp: 85-85
A. Ilhan-Mutlu
DOI: 10.2174/156800962002200207092902



Nordihydroguaiaretic Acid in Therapeutics: Beneficial to Toxicity Profiles and the Search for its Analogs

Volume: 20   Issue: 2
Pp: 86-103
Geraldine Sandana Mala John, Satoru Takeuchi, Ganesh Venkatraman* and Suresh Kumar Rayala*
DOI: 10.2174/1568009619666191022141547



Anti-tumor Activity of Propofol: A Focus on MicroRNAs

Volume: 20   Issue: 2
Pp: 104-114
Milad Ashrafizadeh, Zahra Ahmadi, Tahereh Farkhondeh and Saeed Samarghandian*
DOI: 10.2174/1568009619666191023100046



Novel Mechanistic Insights into the Anti-cancer Mode of Arsenic Trioxide

Volume: 20   Issue: 2
Pp: 115-129
Md Wahiduzzaman, Akinobu Ota* and Yoshitaka Hosokawa
DOI: 10.2174/1568009619666191021122006



Resveratrol as an Adjuvant for Normal Tissues Protection and Tumor Sensitization

Volume: 20   Issue: 2
Pp: 130-145
Keywan Mortezaee, Masoud Najafi*, Bagher Farhood*, Amirhossein Ahmadi*, Dheyauldeen Shabeeb and Ahmed E. Musa
DOI: 10.2174/1568009619666191019143539



Uptake of [¹⁸F]tetrafluoroborate in MCF-7 Breast Cancer Cells is Induced after Stimulation of the Sodium Iodide Symporter

Volume: 20   Issue: 2
Pp: 146-155
Marc Lehmacher*, Antje Stolzenburg and Samuel Samnick
DOI: 10.2174/1568009619666191016145602



CDK12 Promotes Breast Cancer Progression and Maintains Stemness by Activating c-myc/β -catenin Signaling

Volume: 20   Issue: 2
Pp: 156-165
Fang Peng, Chuansheng Yang, Yanan Kong, Xiaojia Huang, Yanyu Chen, Yangfan Zhou, Xinhua Xie* and Peng Liu*
DOI: 10.2174/1568009619666191118113220